P2‐039: PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE. (1st July 2019) - Oliva, Anthony A.; Baumel, Bernard; Brody, Mark; Agronin, Marc; Drouillard, Amy; Pena, Andrea; McClain-Moss, Lisa; Page, Suzanne L.; Perez, Carmen; Landman, Jonathan; Alston, Tequesta; Bookheimer, Susan Y.; et al.